TReatment for ImmUne Mediated PathopHysiology

NCT04862221 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

163

Enrollment

NIH

Sponsor class

Conditions

Acute Liver Failure
Fulminant Hepatic Failure
Hepatic Encephalopathy
Acute Liver Injury
Immune Dysregulation

Interventions

DRUG: High-dose methylprednisolone
DRUG: Equine anti-thymocyte globulin
DRUG: Prednisolone
DRUG: Placebo for prednisolone
DRUG: Placebo for infusions
DRUG: Diphenhydramine
DRUG: Methylprednisolone

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]